Cilostazol Following Peripheral Endovascular Procedures
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
To compare the safety and effectiveness of dual anti-platelet therapy with cilostazol 100 mg
twice daily and aspirin 100 mg daily versus monotherapy with aspirin 100 mg daily in patients
undergoing peripheral angioplasty or stenting or both for the management of peripheral
arterial disease.